Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "NATCO Pharma Limited and Lupin Limited receive approval from U.S. FDA for Eribulin Mesylate Injection".
Press Release Jun 03 2026
Earlier from Natco Pharma
- India’s Natco Pharma to expand into Nigeria, demerge agrochemicals unit
- Press Release Mar 20 2026
- Press Release Mar 03 2026
- Press Release Feb 14 2026